Industry Presentations
Treatment option for R/R LBCL
Presentations
CAR T-cell Therapy for the Treatment of Relapsed/Refractory Large B-cell Lymphoma
Speakers: Ran Reshef, MD Duration: 65 minutes
Presented on: July 6, 2022
*This session is not eligible for AMA PRA Category 1 CreditsTM
Speakers